Literature DB >> 19573717

Three-dimensional coronary visualization, Part 2: 3D reconstruction.

Gert Schoonenberg1, Anne Neubauer, Michael Grass.   

Abstract

Fully automatic generation of a volumetric representation of the coronary artery tree can be achieved by rotational coronary angiography acquisition and three-dimensional tomographic reconstruction. The generated volume datasets can assist the physician during percutaneous coronary interventions by visualizing three-dimensional coronary morphology and offering utility tools to derive various quantitative measurements. These utility tools allow lesion assessment, optimal working-view selection for specific vessel segments, and improved guidance via overlay functionality or follow C-arc. This article gives an overview of reconstruction methods, clinical tools, and present clinical data.

Mesh:

Year:  2009        PMID: 19573717     DOI: 10.1016/j.ccl.2009.03.006

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  4 in total

1.  A model-based reconstruction method for 3-D rotational coronary angiography.

Authors:  Lizhe Xie; Yining Hu; Jean-Claude Nunes; Jean-Jacques Bellanger; Marc Bedossa; Limin Luo; Christine Toumoulin
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

2.  ECG gated tomographic reconstruction for 3-D rotational coronary angiography.

Authors:  Yining Hu; Lizhe Xie; Jean Claude Nunes; Jean Jacques Bellanger; Marc Bedossa; Christine Toumoulin
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

Review 3.  Potential role of three-dimensional rotational angiography and C-arm CT for valvular repair and implantation.

Authors:  Jonathan G Schwartz; Anne M Neubauer; Thomas E Fagan; Niels J Noordhoek; Michael Grass; John D Carroll
Journal:  Int J Cardiovasc Imaging       Date:  2011-03-11       Impact factor: 2.357

4.  Local motion-compensated method for high-quality 3D coronary artery reconstruction.

Authors:  Bo Liu; Xiangzhi Bai; Fugen Zhou
Journal:  Biomed Opt Express       Date:  2016-11-23       Impact factor: 3.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.